The incidence of differentiated thyroid cancer (including papillary, follicular, and Hurthle cell carcinoma) has nearly tripled in the past 20 years. Diagnosis, treatment, and long-term management are evolving with advances in radiology, surgical techniques, nuclear medicine, genetics, and targeted therapeutics. Here we detail the current recommended course of action for differentiated thyroid cancer and options on the horizon.

Original languageEnglish
Pages (from-to)93-98
Number of pages6
JournalMissouri Medicine
Issue number2
StatePublished - Mar 2011


Dive into the research topics of 'Thyroid cancer: what to do after fine needle aspiration.'. Together they form a unique fingerprint.

Cite this